Literature DB >> 28821902

[Chemotherapy: from bacteria killer to antitumor agent : A striking transformation in the term over the last century].

J Konert1.   

Abstract

The term chemotherapy is more than 100 years old and during this period it has been going through decisive changes in terminology. Initially describing an antibacterial therapy it now is known as a part of the new oncologic therapy. Those upheavels and their causes are represented. Conclusively, the evolution of the urooncologic chemotherapy is briefly outlined.

Keywords:  Antibiotic therapy; Infectious diseases; Tumour; Urooncolgy; Wrong paths

Mesh：

Substances：

Year:  2017        PMID： 28821902     DOI： 10.1007/s00120-017-0491-4

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  8 in total

1.  Aspects of the history of therapeutics.

Authors:  E H ACKERKNECHT
Journal:  Bull Hist Med       Date:  1962 Sep-Oct       Impact factor: 1.314

2.  INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE.

Authors:  B ROSENBERG; L VANCAMP; T KRIGAS
Journal:  Nature       Date:  1965-02-13       Impact factor: 49.962

3.  EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ.

Authors:  Adrian P M van der Meijden; Richard Sylvester; Willem Oosterlinck; Eduardo Solsona; Andreas Boehle; Bernard Lobel; Erkki Rintala
Journal:  Eur Urol       Date:  2005-09       Impact factor: 20.096

4.  A sketch of the history of chemotherapy.

Authors:  E M LOURIE
Journal:  Br Med Bull       Date:  1946       Impact factor: 4.291

5.  Cis-diamminedichloroplatinum (NSC-119875): a phase I study.

Authors:  D J Higby; H J Wallace; J F Holland
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

6.  Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.

Authors:  C N Sternberg; A Yagoda; H I Scher; R C Watson; T Ahmed; L R Weiselberg; N Geller; P S Hollander; H W Herr; P C Sogani
Journal:  J Urol       Date:  1985-03       Impact factor: 7.450

7.  [From "Karzinos" to modern urologic oncology : A long way from the first surgical procedures to targeted therapy].

Authors:  J Konert
Journal:  Urologe A       Date:  2016-08       Impact factor: 0.639

8.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.